MARKET

GLMD

GLMD

Galmed Pharmaceu
NASDAQ
0.6210
+0.0210
+3.50%
Opening 10:33 09/22 EDT
OPEN
0.6800
PREV CLOSE
0.6000
HIGH
0.6800
LOW
0.6210
VOLUME
4.38K
TURNOVER
0
52 WEEK HIGH
14.18
52 WEEK LOW
0.6000
MARKET CAP
2.36M
P/E (TTM)
-0.0914
1D
5D
1M
3M
1Y
5Y
Galmed Pharmaceu: [Amend]Report of foreign issuer
Press release · 1d ago
Weekly Report: what happened at GLMD last week (0911-0915)?
Weekly Report · 4d ago
Weekly Report: what happened at GLMD last week (0904-0908)?
Weekly Report · 09/11 10:35
Weekly Report: what happened at GLMD last week (0828-0901)?
Weekly Report · 09/04 21:32
Weekly Report: what happened at GLMD last week (0821-0825)?
Weekly Report · 08/28 10:40
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Investorplace · 08/18 11:27
Drugmakers still chasing potentially lucrative NASH market, despite setbacks
Seeking Alpha · 08/14 17:19
Galmed Pharmaceu: Correspondence
Press release · 08/11 16:06
More
About GLMD
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).

Webull offers kinds of Galmed Pharmaceuticals Ltd stock information, including NASDAQ:GLMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GLMD stock methods without spending real money on the virtual paper trading platform.